Rigel Pharmaceuticals
RIGL
#6623
Rank
โ‚ฌ0.73 B
Marketcap
39,02ย โ‚ฌ
Share price
-1.85%
Change (1 day)
6.39%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): โ‚ฌ78.58 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.27 Billion. In 2025 the company made an earning of โ‚ฌ0.11 Billion, an increase over its 2024 earnings that were of โ‚ฌ23.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ78.58 M-33.06%
2025 โ‚ฌ0.11 B391.35%
2024 โ‚ฌ23.89 M-244.27%
2023 -โ‚ฌ16.57 Million-66.79%
2022 -โ‚ฌ49.88 Million340.73%
2021 -โ‚ฌ11.32 Million-56.15%
2020 -โ‚ฌ25.82 Million-57.34%
2019 -โ‚ฌ60.51 Million-7.66%
2018 -โ‚ฌ65.53 Million-9.47%
2017 -โ‚ฌ72.38 Million24.46%
2016 -โ‚ฌ58.16 Million23.63%
2015 -โ‚ฌ47.04 Million-43.29%
2014 -โ‚ฌ82.96 Million2.5%
2013 -โ‚ฌ80.94 Million
2010 โ‚ฌ34.41 M-133.97%
2009 -โ‚ฌ0.11 Billion-18.49%
2008 -โ‚ฌ0.13 Billion71.91%
2007 -โ‚ฌ72.3 Million84.74%
2006 -โ‚ฌ39.14 Million-10.17%
2005 -โ‚ฌ43.57 Million-15.73%
2004 -โ‚ฌ51.7 Million39.29%
2003 -โ‚ฌ37.12 Million10.3%
2002 -โ‚ฌ33.66 Million48.3%
2001 -โ‚ฌ22.7 Million-2.13%
2000 -โ‚ฌ23.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚ฌ10.04 B 11,994.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ13.71 B 16,412.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-โ‚ฌ0.11 Billion-220.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-โ‚ฌ0.12 Billion-242.92%๐Ÿ‡บ๐Ÿ‡ธ USA